Product Name
ATP6V1B2, Blocking Peptide
Full Product Name
ATP6V1B2 Peptide - middle region
Product Gene Name
ATP6V1B2 blocking peptide
[Similar Products]
Product Synonym Gene Name
ATP6B1B2; ATP6B2; HO57; VATB; VPP3; Vma2[Similar Products]
ATP6V1B2 peptide (MBS3237653) is used for blocking the activity of ATP6V1B2 antibody (MBS3212706)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
3D Structure
ModBase 3D Structure for P21281
Form/Format
Lyophilized powder
Preparation and Storage
Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20 degree C. Avoid repeat freeze-thaw cycles.
Other Notes
Small volumes of ATP6V1B2 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
Related Product Information for
ATP6V1B2 blocking peptide
This is a synthetic peptide designed for use in combination with anti-ATP6V1B2 antibody made
Target Description: ATP6V1B2 is a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A, three B, and two G subunits, as well as a C, D, E, F, and H subunit. The V1 domain contains the ATP catalytic site. ATP6V1B2 is one of two V1 domain B subunit isoforms and is the only B isoform highly expressed in osteoclasts.This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A, three B, and two G subunits, as well as a C, D, E, F, and H subunit. The V1 domain contains the ATP catalytic site. The protein encoded by this gene is one of two V1 domain B subunit isoforms and is the only B isoform highly expressed in osteoclasts. Publication Note: This RefSeq record includes a subset of the publications that are available for this gene. Please see the Entrez Gene record to access additional publications.
Product Categories/Family for ATP6V1B2 blocking peptide
Peptide
Applications Tested/Suitable for ATP6V1B2 blocking peptide
Western Blot (WB)
NCBI/Uniprot data below describe general gene information for ATP6V1B2. It may not necessarily be applicable to this product.
NCBI Accession #
NP_001684
[Other Products]
NCBI GenBank Nucleotide #
NM_001693
[Other Products]
UniProt Primary Accession #
P21281
[Other Products]
UniProt Related Accession #
P21281[Other Products]
NCBI Official Full Name
V-type proton ATPase subunit B, brain isoform
NCBI Official Synonym Full Names
ATPase H+ transporting V1 subunit B2
NCBI Official Symbol
ATP6V1B2 [Similar Products]
NCBI Official Synonym Symbols
DOOD; HO57; VATB; VPP3; Vma2; ZLS2; ATP6B2; ATP6B1B2
[Similar Products]
NCBI Protein Information
V-type proton ATPase subunit B, brain isoform
UniProt Protein Name
V-type proton ATPase subunit B, brain isoform
UniProt Synonym Protein Names
Endomembrane proton pump 58 kDa subunit; HO57; Vacuolar proton pump subunit B 2
Protein Family
V-type proton ATPase
UniProt Gene Name
ATP6V1B2 [Similar Products]
UniProt Synonym Gene Names
ATP6B2; VPP3; V-ATPase subunit B 2 [Similar Products]
UniProt Entry Name
VATB2_HUMAN
NCBI Summary for ATP6V1B2
This gene encodes a component of vacuolar ATPase (V-ATPase), a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, receptor-mediated endocytosis, and synaptic vesicle proton gradient generation. V-ATPase is composed of a cytosolic V1 domain and a transmembrane V0 domain. The V1 domain consists of three A, three B, and two G subunits, as well as a C, D, E, F, and H subunit. The V1 domain contains the ATP catalytic site. The protein encoded by this gene is one of two V1 domain B subunit isoforms and is the only B isoform highly expressed in osteoclasts. [provided by RefSeq, Jul 2008]
UniProt Comments for ATP6V1B2
ATP6V1B2: Non-catalytic subunit of the peripheral V1 complex of vacuolar ATPase. V-ATPase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells. Belongs to the ATPase alpha/beta chains family.
Protein type: EC 3.6.3.14; Energy Metabolism - oxidative phosphorylation; Hydrolase
Chromosomal Location of Human Ortholog: 8p21.3
Cellular Component: ruffle; microvillus; intracellular membrane-bound organelle; lysosomal membrane; integral to membrane; melanosome; plasma membrane; endomembrane system; cytosol
Molecular Function: hydrogen ion transmembrane transporter activity; hydrogen ion transporting ATPase activity, rotational mechanism; ATP binding
Biological Process: ATP metabolic process; interaction with host; proton transport; cellular iron ion homeostasis; ATP hydrolysis coupled proton transport; insulin receptor signaling pathway; transferrin transport; transmembrane transport
Disease: Zimmermann-laband Syndrome 2
Research Articles on ATP6V1B2
1. Both B1 and B2 subunits of the V-ATPase are detectable in human urinary exosomes, and acid and alkali loading or distal renal tubular acidosis cause changes in the B1 but not B2 subunit abundance in urinary exosomes.
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.
It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.